Germany
TRiCares GmbH, founded in 2018, is positioned at the forefront of medical innovation, specializing in transcatheter minimally invasive technology. The company’s primary focus is on the development of a groundbreaking tricuspid heart valve replacement system. This innovation is designed to enhance the quality of life for cardiac patients by ensuring both safety and efficacy.
The company’s slogan, "Made to fit", encapsulates its commitment to creating solutions that address the unique needs of patients. A dedication to excellence is evident in TRiCares' emphasis on ease of use for healthcare professionals, which could streamline clinical procedures.
Despite its promising technological offerings, TRiCares lacks public information regarding recent investments or specific investor relationships. This represents a potential area of opportunity for VCs seeking to engage with a company on the cusp of significant healthcare impact, assuming the company secures necessary certifications and establishes substantial market traction.
